secure patient data

IBM Watson Health has signed a 2-year research initiative with the FDA to leverage blockchain technology to define a secure, efficient, and scalable exchange of patient data. As part of the two-year agreement, IBM and the FDA will explore the exchange of owner mediated data from several sources, such as EMRs, clinical trials, genomic data, and health data from mobile devices, wearables and the "Internet of Things." The initial focus will be on oncology-related data with plans to share initial
Read More